SWP
UTHR icon

Strategic Wealth Partners’s United Therapeutics UTHR Stock Holding History

Strategic Wealth Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Hold
64
– – ﹤0.01% 618
2026
Q1 		$38K Hold
64
– – ﹤0.01% 563
2025
Q4 		$31.2K Hold
64
– – ﹤0.01% 609
2025
Q3 		$26.8K Hold
64
– – ﹤0.01% 670
2025
Q2 		$18.4K Buy
+64
New +$19.1K ﹤0.01% 666

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Strategic Wealth Partners's UTHR Position: Q2 2026 in Review

Strategic Wealth Partners held its United Therapeutics (UTHR) position steady in Q2 2026 at 64 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Strategic Wealth Partners first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $38K in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Strategic Wealth Partners held 64 shares of United Therapeutics worth $34.7K as of Q2 2026.
  • Strategic Wealth Partners left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #618 holding.
  • Strategic Wealth Partners first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Strategic Wealth Partners's United Therapeutics position peaked at $38K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.